Home
>
National Drug Code (NDC)
>
PRADAXA
PRADAXA - 21695-899-60 - (dabigatran etexilate mesylate)
Drug Information of PRADAXA
| Product NDC: | 21695-899 |
| Proprietary Name: | PRADAXA |
| Non Proprietary Name: | dabigatran etexilate mesylate |
| Active Ingredient(s): | 150 mg/1 & nbsp; dabigatran etexilate mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PRADAXA
| Product NDC: | 21695-899 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022512 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101026 |
Package Information of PRADAXA
| Package NDC: | 21695-899-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (21695-899-60) |
NDC Information of PRADAXA
| NDC Code | 21695-899-60 |
| Proprietary Name | PRADAXA |
| Package Description | 60 CAPSULE in 1 BOTTLE (21695-899-60) |
| Product NDC | 21695-899 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dabigatran etexilate mesylate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20101026 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | DABIGATRAN ETEXILATE MESYLATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
